London (United Kingdom) – Stallergenes Greer plc (the “Company”) (Euronext Paris: STAGR), a biopharmaceutical company specializing in treatments for respiratory allergies, today announced its financial calendar for the year 2016:
|FY 2015 Results||27th April 2016|
|Investor and Analyst Call||28th April 2016|
|Annual Report Filing||29th April 2016|
|Annual General Meeting||9th June 2016|
|1st semester 2016 Results||25th August 2016|
|Strategy and R&D Day||November 2016|
Please note that Stallergenes Greer will release its financial results for the year 2015 the 27th of April after market close. Fereydoun Firouz, Chief Executive Officer, and Peter Bühler, Chief Financial Officer, will host the investor and analyst call on the 28th of April at 2:00 pm (CET).
The Company’s Annual General Meeting will be held on the 9th of June in Paris, France. Stallergenes Greer will hold a Strategy and R&D Day in Antony, France in November 2016.